New insights concerning insulin synthesis and its secretion in rat hippocampus and cerebral cortex: Amyloid-β1-42-induced reduction of proinsulin level via glycogen synthase kinase-3β

Cellular Signalling

Volumn 26, Issue 2, 2014, Pages 253-259

  Nemoto, Takayuki ^a   Toyoshima Aoyama, Fumiyo ^a   Yanagita, Toshihiko ^a   Maruta, Toyoaki ^a   Fujita, Hiroshi ^a   Koshida, Tomohiro ^a   Yonaha, Tetsu ^a   Wada, Akihiko ^b   Sawaguchi, Akira ^a   Murakami, Manabu ^c  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b KYUSHU UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^c HIROSAKI UNIVERSITY   (Japan)

Author keywords

A 1 42; Alzheimer's disease; GSK 3 ; Hippocampal neurons; PHluorin; Proinsulin

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CAPS2 PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN; LITHIUM; MESSENGER RNA; PROINSULIN; REGULATOR PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN CORTEX; CELL VACUOLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HIPPOCAMPAL NEURONAL CULTURE; HIPPOCAMPUS; INSULIN RELEASE; INSULIN SYNTHESIS; NERVE CELL MEMBRANE STEADY POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ALZHEIMER'S DISEASE; AMYLOID-Β(1-42); AΒ(1-42); CA(2+)-DEPENDENT ACTIVATOR PROTEIN FOR SECRETION 2; CAPS2; CEREBROSPINAL FLUID; CSF; DIMETHYL SULFOXIDE; DMSO; GLYCOGEN SYNTHASE KINASE-3Α; GLYCOGEN SYNTHASE KINASE-3Β; GSK-3Α; GSK-3Β; HIPPOCAMPAL NEURONS; PH-SENSITIVE GREEN FLUORESCENT PROTEIN; PHLUORIN; PROINSULIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RT-PCR;

AMYLOID BETA-PEPTIDES; ANIMALS; CALCIUM-BINDING PROTEINS; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; EXOCYTOSIS; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; GREEN FLUORESCENT PROTEINS; HIPPOCAMPUS; INSULIN; LITHIUM CHLORIDE; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; PROINSULIN; RATS; RATS, WISTAR; RECOMBINANT FUSION PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84889032585     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2013.11.017     Document Type: Article

References (33)

1. Margolis R.U., Altszuler N. Nature 1967, 215:1375-1376.
2. Banks W.A., Jaspan J.B., Huang W., Kastin A.J. Peptides 1997, 18:1423-1429.
3. Havrankova J., Roth J., Brownstein M. Proc. Natl. Acad. Sci. U. S. A. 1978, 75:5737-5741.
4. Ghasemi R., Dargahi L., Haeri A., Moosavi M., Mohamed Z., Ahmadiani A. Mol. Neurobiol. 2013, 47:1045-1065.
5. Wada A., Yokoo H., Yanagita T., Kobayashi H. J. Pharmacol. Sci. 2005, 99:128-143.
6. Craft S., Peskind E., Schwartz M.W., Schellenberg G.D., Raskind M., Porte D. Neurology 1998, 50:164-168.
7. Craft S., Baker L.D., Montine T.J., Minoshima S., Watson G.S., Claxton A., Arbuckle M., Callaghan M., Tsai E., Plymate S.R., Green P.S., Leverenz J., Cross D., Gerton B. Arch. Neurol. 2012, 69:29-38.
8. Freiherr J., Hallschmid M., Frey W.H., Brünner Y.F., Chapman C.D., Hölscher C., Craft S., De Felice F.G., Benedict C. CNS Drugs 2013, 27:505-514.
9. Wada A. J. Pharmacol. Sci. 2009, 110:14-28.
10. Alhebshi A.H., Gotoh M., Suzuki I. Biochem. Biophys. Res. Commun. 2013, 433:362-367.
11. Li L., Liu Z., Liu J., Tai X., Hu X., Liu X., Wu Z., Zhang G., Shi M., Zhao G. Neurobiol. Dis. 2013, 54:320-328.
12. De Sarno P., Li X., Jope R.S. Neuropharmacology 2002, 43:1158-1164.
13. De Ferrari G.V., Chacón M.A., Barría M.I., Garrido J.L., Godoy J.A., Olivares G., Reyes A.E., Alvarez A., Bronfman M., Inestrosa N.C. Mol. Psychiatry 2003, 8:195-208.
14. Liu S.J., Zhang A.H., Li H.L., Wang Q., Deng H.M., Netzer W.J., Xu H., Wang J.Z. J. Neurochem. 2003, 87:1333-1344.
15. Rockenstein E., Torrance M., Adame A., Mante M., Bar-on P., Rose J.B., Crews L., Masliah E. J. Neurosci. 2007, 27:1981-1991.
16. Ohara-Imaizumi M., Nakamichi Y., Tanaka T., Katsuta H., Ishida H., Nagamatsu S. Biochem. J. 2002, 363:73-80.
17. Kuwabara T., Kagalwala M.N., Onuma Y., Ito Y., Warashina M., Terashima K., Sanosaka T., Nakashima K., Gage F.H., Asashima M. EMBO Mol. Med. 2011, 3:742-754.
18. Schechter R., Whitmire J., Wheet G.S., Beju D., Jackson K.W., Harlow R., Gavin J.R. Brain Res. 1994, 636:9-27.
19. Birch N.P., Christie D.L., Renwick A.G. FEBS Lett. 1984, 168:299-302.
20. Shinoda Y., Sadakata T., Nakao K., Katoh-Semba R., Kinameri E., Furuya A., Yanagawa Y., Hirase H., Furuichi T. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:373-378.
21. Speidel D., Salehi A., Obermueller S., Lundquist I., Brose N., Renström E., Rorsman P. Cell Metab. 2008, 7:57-67.
22. Gil-Bea F.J., Solas M., Solomon A., Mugueta C., Winblad B., Kivipelto M., Ramirez M.J., Cedazo-Mínguez A. J. Alzheimers Dis. 2010, 22:405-413.
23. Steen E., Terry B.M., Rivera E.J., Cannon J.L., Neely T.R., Tavares R., Xu X.J., Wands J.R., de la Monte S.M. J. Alzheimers Dis. 2005, 7:63-80.
24. DaRocha-Souto B., Coma M., Pérez-Nievas B.G., Scotton T.C., Siao M., Sánchez-Ferrer P., Hashimoto T., Fan Z., Hudry E., Barroeta I., Serenó L., Rodríguez M., Sánchez M.B., Hyman B.T., Gómez-Isla T. Neurobiol. Dis. 2012, 45:425-437.
25. Sofola O., Kerr F., Rogers I., Killick R., Augustin H., Gandy C., Allen M.J., Hardy J., Lovestone S., Partridge L. PLoS Genet. 2010, 6:e1001087.
26. Hernández F., Borrell J., Guaza C., Avila J., Lucas J.J. J. Neurochem. 2002, 83:1529-1533.
27. Bartl J., Meyer A., Brendler S., Riederer P., Grünblatt E. J. Neural Transm. 2013, 120:113-120.
28. Nemoto T., Yanagita T., Satoh S., Maruta T., Kanai T., Murakami M., Wada A. Neurochem. Int. 2011, 59:880-888.
29. Leyhe T., Eschweiler G.W., Stransky E., Gasser T., Annas P., Basun H., Laske C. J. Alzheimers Dis. 2009, 16:649-656.
30. Chen G., Rajkowska G., Du F., Seraji-Bozorgzad N., Manji H.K. J. Neurochem. 2000, 75:1729-1734.
31. Wexler E.M., Geschwind D.H., Palmer T.D. Mol. Psychiatry 2008, 13:285-292.
32. Kim W.Y., Wang X., Wu Y., Doble B.W., Patel S., Woodgett J.R., Snider W.D. Nat. Neurosci. 2009, 12:1390-1397.
33. Morales-Garcia J.A., Luna-Medina R., Alonso-Gil S., Sanz-Sancristobal M., Palomo V., Gil C., Santos A., Martinez A., Perez-Castillo A. ACS Chem. Neurosci. 2012, 3:963-971.